Robert A. Forbes, PhD

home / authors / robert-a-forbes-phd

Articles

January 16th 2012

Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression

Teresa B. Gibson, PhD Yonghua Jing, PhD Jill E. Bagalman, MSW Zhun Cao, PhD John A. Bates, PhD Tony Hebden, PhD Robert A. Forbes, PhD Jalpa A. Doshi, PhD

Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.

December 22nd 2011

Adjunctive Aripiprazole for Depression: Predictive Value of Early Assessment

David J. Muzina, MD Jessie S. Chambers, PhD Trixia A. Camacho, PharmD James M. Eudicone, MS, MBA Robert A. Forbes, PhD Robert M. Berman, MD Ross A. Baker, PhD

In treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.